文献速递妇科产科

卵巢癌初治期间身体成分变化与预后:基于AI体积测量技术的回顾性研究

Prognostic implications of body composition change during primary treatment in patients with ovarian cancer: A retrospective study using an artificial intelligence-based volumetric technique.
PubMed 文献 · Gynecol Oncol · 2021-05-14

该回顾性研究纳入208例上皮性卵巢癌患者,利用人工智能工具自动测量初治前后CT腰层面骨骼肌、内脏脂肪和皮下脂肪体积。结果显示BMI下降≥5%是PFS和OS的独立不良预后因素,肌肉丢失≥10%和内脏脂肪丢失≥20%与OS较差相关但不影响复发。

要点

  • BMI下降≥5%是上皮性卵巢癌PFS和OS的独立不良预后因素。
  • 肌肉丢失≥10%和内脏脂肪丢失≥20%与OS增加相关,但不影响疾病复发。
  • 晚期亚组(n=173)结果与总体一致。

核心结论

  • 上皮性卵巢癌患者初治期间BMI及腰层面骨骼肌和内脏脂肪体积变化与生存结局相关。

研究设计与样本

  • 回顾性研究,纳入2010至2019年诊断的上皮性卵巢癌患者共208例。
  • 使用基于人工智能的工具从治疗前后CT扫描腰层面自动测量骨骼肌、内脏脂肪和皮下脂肪体积。

主要发现

  • 初治期间BMI及腰层面骨骼肌和内脏脂肪体积显著下降。
  • BMI下降≥5%者PFS和OS显著差于BMI下降<5%者。
  • 多因素分析中BMI下降≥5%是PFS独立不良预后因素(校正HR 1.565;95%CI 1.074-2.280;P=0.020)和OS独立不良预后因素(校正HR 2.754;95%CI 1.382-5.488;P=0.004)。
  • 肌肉丢失≥10%和内脏脂肪丢失≥20%均与死亡率增加相关但不影响疾病复发。
  • 多因素分析中肌肉丢失≥10%(校正HR 2.069;95%CI 1.055-4.058;P=0.034)和内脏脂肪丢失≥20%(校正HR 2.292;95%CI 1.023-5.133;P=0.044)是OS不良预后因素。

临床怎么用

  • 初治期间可关注上皮性卵巢癌患者BMI及身体成分变化,BMI下降≥5%提示预后较差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the impact of changes in body composition during primary treatment on survival outcomes in patients with epithelial ovarian cancer (EOC). METHODS: We retrospectively identified patients diagnosed with EOC between 2010 and 2019. Using an artificial intelligence-based tool, the volumes of skeletal muscle, visceral fat, and subcutaneous fat were measured automatically at the waist level from pre-treatment and post-treatment computed tomography scans. Associations between changes in body mass index (BMI) and volume of each body composition component and survival outcomes were evaluated. RESULTS: A total of 208 patients were included. A significant decrease in BMI and waist volumes of skeletal muscle and visceral fat was observed during the primary treatment. Patients with BMI loss ≥5% showed significantly worse progression-free survival (PFS) and overall survival (OS) than those with BMI loss <5%. In multivariate analyses adjusting for clinicopathologic factors, BMI loss ≥5% was identified as an independent poor prognostic factor for PFS (adjusted HR, 1.565; 95% CI, 1.074-2.280; P = 0.020) and OS (adjusted HR, 2.754; 95% CI, 1.382-5.488; P = 0.004). Meanwhile, both muscle loss ≥10% and visceral fat loss ≥20% were associated with an increased mortality rate but did not affect disease recurrence. In multivariate analyses, muscle loss ≥10% (adjusted HR, 2.069; 95% CI, 1.055-4.058; P = 0.034) and visceral fat loss ≥20% (adjusted HR, 2.292; 95% CI, 1.023-5.133; P = 0.044) were poor prognostic factors for OS. Consistent results were observed in the advanced-stage disease subgroup (n = 173). CONCLUSIONS: Changes in BMI and waist volume of skeletal muscle and visceral fat were associated with survival outcomes in patients with EOC.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Kim SI, Yoon S, Kim TM, et al. Prognostic implications of body composition change during primary treatment in patients with ovarian cancer: A retrospective study using an artificial intelligence-based volumetric technique. Gynecol Oncol. 2021. PMID: 33994146. doi:10.1016/j.ygyno.2021.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。